Tinkerer, I think you hit the nail on the head with your comments on VRNG and for that matter all of the patent monetization stocks. Other than VHC which seems to be on some strong steroids since it trades at over $17 a share with no revenue most of these stocks you should sell on news and buy back when the bleeding subsides. For longs like me its hard to do but its been proven over and over. Thank god VRNG will have some news momentum a week from today with the conference call.
The day traders will drop us down now so when it rises back up next week we will be back to $4.00 instead of the dreaded $5.00.